vs
Side-by-side financial comparison of Coda Octopus Group, Inc. (CODA) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Spero Therapeutics, Inc. is the larger business by last-quarter revenue ($12.6M vs $7.3M, roughly 1.7× Coda Octopus Group, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 14.1%, a 236.6% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 43.8%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 27.7%).
CODA plc was a mid-sized international financial software company based in the United Kingdom. Founded in 1979, it was purchased in 2008 by Unit4, a supplier of enterprise software, based in the Netherlands. CODA creates, markets and implements a range of business software systems designed for finance directors and finance departments. These include:financial management systems like accounting software and procurement software: financial analysis applications like reporting, consolidation and...
CODA vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.3M | $12.6M |
| Net Profit | $1.0M | $31.5M |
| Gross Margin | 67.6% | — |
| Operating Margin | 19.3% | — |
| Net Margin | 14.1% | 250.7% |
| Revenue YoY | 43.8% | 24080.8% |
| Net Profit YoY | 214.3% | 250.9% |
| EPS (diluted) | $0.10 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.3M | $12.6M | ||
| Q3 25 | $7.1M | $0 | ||
| Q2 25 | $7.0M | $0 | ||
| Q1 25 | $5.2M | $12.0K | ||
| Q4 24 | $5.1M | $52.0K | ||
| Q3 24 | $5.5M | $65.0K | ||
| Q2 24 | $5.3M | $114.0K | ||
| Q1 24 | $4.5M | $140.0K |
| Q4 25 | $1.0M | $31.5M | ||
| Q3 25 | $1.3M | $-7.4M | ||
| Q2 25 | $908.8K | $-1.7M | ||
| Q1 25 | $913.0K | $-13.9M | ||
| Q4 24 | $326.2K | — | ||
| Q3 24 | $1.3M | $-17.1M | ||
| Q2 24 | $1.4M | $-17.9M | ||
| Q1 24 | $629.9K | $-12.7M |
| Q4 25 | 67.6% | — | ||
| Q3 25 | 68.3% | — | ||
| Q2 25 | 64.1% | — | ||
| Q1 25 | 65.8% | — | ||
| Q4 24 | 65.3% | — | ||
| Q3 24 | 73.9% | — | ||
| Q2 24 | 70.2% | — | ||
| Q1 24 | 69.2% | — |
| Q4 25 | 19.3% | — | ||
| Q3 25 | 19.5% | — | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | 12.7% | -122758.3% | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 25.4% | -28604.6% | ||
| Q2 24 | 25.4% | -16720.2% | ||
| Q1 24 | 12.4% | -9987.1% |
| Q4 25 | 14.1% | 250.7% | ||
| Q3 25 | 18.2% | — | ||
| Q2 25 | 13.0% | — | ||
| Q1 25 | 17.5% | -115550.0% | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | 23.3% | -26380.0% | ||
| Q2 24 | 26.6% | -15668.4% | ||
| Q1 24 | 14.1% | -9049.3% |
| Q4 25 | $0.10 | $0.56 | ||
| Q3 25 | $0.11 | $-0.13 | ||
| Q2 25 | $0.08 | $-0.03 | ||
| Q1 25 | $0.08 | $-0.25 | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.11 | $-0.32 | ||
| Q2 24 | $0.13 | $-0.33 | ||
| Q1 24 | $0.06 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $28.7M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.1M | $59.0M |
| Total Assets | $64.5M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.7M | $40.3M | ||
| Q3 25 | $26.2M | $48.6M | ||
| Q2 25 | $24.5M | $31.2M | ||
| Q1 25 | $22.5M | $48.9M | ||
| Q4 24 | $22.5M | $52.9M | ||
| Q3 24 | $25.2M | $76.3M | ||
| Q2 24 | $23.7M | $63.5M | ||
| Q1 24 | $25.0M | $82.3M |
| Q4 25 | $58.1M | $59.0M | ||
| Q3 25 | $57.3M | $26.5M | ||
| Q2 25 | $55.9M | $32.8M | ||
| Q1 25 | $53.1M | $33.8M | ||
| Q4 24 | $53.1M | $46.1M | ||
| Q3 24 | $52.8M | $65.5M | ||
| Q2 24 | $51.1M | $80.5M | ||
| Q1 24 | $50.1M | $96.2M |
| Q4 25 | $64.5M | $68.9M | ||
| Q3 25 | $61.9M | $54.2M | ||
| Q2 25 | $60.6M | $62.1M | ||
| Q1 25 | $56.9M | $77.7M | ||
| Q4 24 | $57.5M | $110.5M | ||
| Q3 24 | $55.9M | $135.2M | ||
| Q2 24 | $54.0M | $149.9M | ||
| Q1 24 | $53.0M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9M | $-8.4M |
| Free Cash FlowOCF − Capex | $2.5M | — |
| FCF MarginFCF / Revenue | 34.9% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 2.83× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $6.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9M | $-8.4M | ||
| Q3 25 | $2.2M | $17.4M | ||
| Q2 25 | $1.5M | $-17.7M | ||
| Q1 25 | $641.5K | $-4.0M | ||
| Q4 24 | $2.0M | $-23.4M | ||
| Q3 24 | $1.7M | $12.8M | ||
| Q2 24 | $-955.8K | $-18.7M | ||
| Q1 24 | $-298.0K | $5.9M |
| Q4 25 | $2.5M | — | ||
| Q3 25 | $1.6M | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $513.4K | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $-1.1M | — | ||
| Q1 24 | $-433.6K | — |
| Q4 25 | 34.9% | — | ||
| Q3 25 | 22.6% | — | ||
| Q2 25 | 19.9% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 38.5% | — | ||
| Q3 24 | 28.2% | — | ||
| Q2 24 | -20.9% | — | ||
| Q1 24 | -9.7% | — |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 8.6% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 2.9% | — | ||
| Q1 24 | 3.0% | — |
| Q4 25 | 2.83× | -0.26× | ||
| Q3 25 | 1.72× | — | ||
| Q2 25 | 1.61× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 6.11× | — | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | -0.68× | — | ||
| Q1 24 | -0.47× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CODA
| Segment Reporting | $3.1M | 42% |
| Transferred At Point In Time | $1.8M | 24% |
| Precision Acoustics Limited | $1.3M | 18% |
| Other | $1.1M | 15% |
SPRO
Segment breakdown not available.
